Epicondylitis - Treatment with fluoroquinolone antibiotics Factor
Fluoroquinolone antibiotics include: norfloxacin (Noroxin), ciprofloxacin (Ciprol, Ciproxin), gatifloxacin (Tequin), and moxifloxacin (Avelox). These antibiotics can be given either orally, topically or intravenously. They are most commonly used for treatment of lower respiratory tract infection, ear infections, urinary tract infection, bacterial gastroenteritis, infectious diarrhoea, enteric fever and bone infections.
Last reviewed for CCPS 20 April 2005.
Preliminary questions [34351]
34373 there is some evidence that treatment with fluoroquinolone antibiotics may be a factor in the development of the condition under consideration.
34374 the veteran underwent treatment with fluoroquinolone antibiotics at some time.
34375 the veteran underwent treatment with fluoroquinolone antibiotics for treatment of an illness or injury which is identifiable.
34376 the veteran has established the causal connection between treatment with fluoroquinolone antibiotics and VEA service for the clinical onset of epicondylitis.
34378 the veteran has established the causal connection between treatment with fluoroquinolone antibiotics and eligible service for the clinical onset of epicondylitis.
or
34377 the veteran has established the causal connection between treatment with fluoroquinolone antibiotics and operational service for the clinical onset of epicondylitis.
Clinical onset and operational service [34377]
34379 for the identified illness or injury, the veteran underwent treatment with fluoroquinolone antibiotics within the fourteen days before the clinical onset of the condition under consideration.
34381 the identified illness or injury, for which the veteran underwent treatment with fluoroquinolone antibiotics, is causally related to operational service.
Clinical onset and eligible service [34378]
34380 for the identified illness or injury, the veteran underwent treatment with fluoroquinolone antibiotics within the seven days before the clinical onset of the condition under consideration.
34382 the identified illness or injury, for which the veteran underwent treatment with fluoroquinolone antibiotics, is causally related to eligible service.